Current state of heart transplantation

Area of Science:

• Cardiology
• Immunology
• Surgical Innovation

Background:

• Heart transplantation is an established treatment for terminal heart disease.
• Significant advancements have been made in various aspects of heart transplantation.
• Cyclosporin A marked a pivotal moment in the field.

Purpose of the Study:

• To review the evolution and impact of heart transplantation.
• To highlight key improvements in transplant procedures and patient care.
• To underscore the role of immunosuppressive therapy in transplant success.

Main Methods:

• Review of medical literature and clinical practice evolution.
• Analysis of donor and recipient selection criteria.
• Examination of immunosuppressive strategies and management of complications.

Main Results:

• Improved donor/recipient selection and management.
• Enhanced organ preservation and immunosuppressive techniques.
• Effective prophylaxis, diagnosis, and treatment of infections.
• Cyclosporin A introduction led to better survival and reduced morbidity.
• Shorter hospital stays and decreased costs were observed.

Conclusions:

• Heart transplantation is a widely accepted and effective therapy.
• Immunosuppression, particularly cyclosporin A, revolutionized heart transplantation outcomes.
• Continued advancements have made heart transplantation more accessible and successful.